[HTML][HTML] The role of co-infections and secondary infections in patients with COVID-19

C Feldman, R Anderson - Pneumonia, 2021 - Springer
Background It has been recognised for a considerable time-period, that viral respiratory
infections predispose patients to bacterial infections, and that these co-infections have a …

[HTML][HTML] Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

DL Monnet, S Harbarth - Eurosurveillance, 2020 - eurosurveillance.org
Since the beginning of 2020, the ongoing coronavirus disease (COVID-19) pandemic has
resulted in the deaths of more than 250,000 patients in the European Union/European …

[HTML][HTML] Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study

L Piroth, J Cottenet, AS Mariet, P Bonniaud… - The Lancet …, 2021 - thelancet.com
Background To date, influenza epidemics have been considered suitable for use as a model
for the COVID-19 epidemic, given that they are respiratory diseases with similar modes of …

[HTML][HTML] Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy

AD Bendala Estrada, J Calderón Parra… - BMC infectious …, 2021 - Springer
Abstract Background Since December 2019, the COVID-19 pandemic has changed the
concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to …

[HTML][HTML] The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship

SH Subramanya, DM Czyż, KP Acharya, H Humphreys - Virusdisease, 2021 - Springer
The rapid emergence and spread of antimicrobial resistance continue to kill an estimated
700,000 people annually, and this number is projected to increase ten-fold by 2050. With the …

[HTML][HTML] Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University Hospital in Rome

A Iacovelli, A Oliva, G Siccardi, A Tramontano… - BMC Pulmonary …, 2023 - Springer
Background Little is known on the burden of co-infections and superinfections in a specific
setting such as the respiratory COVID-19 sub-intensive care unit. This study aims to (i) …

[HTML][HTML] Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance …

HH Liu, D Yaron, AS Piraino, L Kapelusznik - Annals of clinical …, 2021 - Springer
Abstract Background Coronavirus SARS-CoV-2 causes COVID-19 illness which can
progress to severe pneumonia. Empiric antibacterials are often employed though frequency …

[HTML][HTML] Microbial diversity and antimicrobial susceptibility in endotracheal tube biofilms recovered from mechanically ventilated COVID-19 patients

F van Charante, A Wieme, P Rigole, E De Canck… - Biofilm, 2022 - Elsevier
In patients with acute respiratory failure, mechanical ventilation through an endotracheal
tube (ET) may be required to correct hypoxemia and hypercarbia. However, biofilm …

[HTML][HTML] Secondary bacterial infections in patients with coronavirus disease 2019-associated pneumonia

O Aydemir, Y Aydemir, EÖ Şahin, F Şahin… - Revista da Associação …, 2022 - SciELO Brasil
SUMMARY OBJECTIVE: The vast majority of patients who hospitalized with coronavirus
disease 2019 are given empirical antibiotic therapy. However, information on the frequency …

[HTML][HTML] A Metabolomics approach for the diagnosis Of SecondAry InfeCtions in COVID-19 (MOSAIC): a study protocol

G McCreath, PD Whitfield, AJ Roe, MJ Watson… - BMC Infectious …, 2021 - Springer
Background Critically ill patients with COVID-19 are at an increased risk of developing
secondary bacterial infections. These are both difficult to diagnose and are associated with …